Y-Intercept (HK)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Sell
1,245
-4,669
-79% -$831K 0.01% 1484
2026
Q1
$1.02M Sell
5,914
-3,454
-37% -$640K 0.02% 1021
2025
Q4
$1.87M Buy
9,368
+1,842
+24% +$334K 0.04% 657
2025
Q3
$1.18M Buy
+7,526
New +$1.2M 0.03% 900
2025
Q2
Sell
-3,760
Closed -$566K 1686
2025
Q1
$566K Buy
+3,760
New +$630K 0.04% 645
2023
Q3
Sell
-10,712
Closed -$2.25M 1136
2023
Q2
$2.25M Buy
10,712
+8,293
+343% +$1.65M 0.24% 94
2023
Q1
$488K Buy
+2,419
New +$548K 0.06% 544
2022
Q3
Sell
-5,558
Closed -$1.19M 1017
2022
Q2
$1.19M Buy
5,558
+4,727
+569% +$1.16M 0.16% 187
2022
Q1
$236K Buy
+831
New +$256K 0.05% 547

Other funds holding CRL